SINTX Technologies to Present at the LD Micro Invitational XVI Conference
Rhea-AI Summary
SINTX Technologies (NASDAQ:SINT) will present at the LD Micro Invitational XVI Conference in Los Angeles at the Luxe Sunset Blvd Hotel.
Management plans to discuss commercialization progress, product development, and manufacturing initiatives for its silicon nitride biomaterials platform and will hold one-on-one investor meetings. A live webcast will be available.
AI-generated analysis. Not financial advice.
Positive
- None.
Negative
- None.
Key Figures
Market Reality Check
Peers on Argus
SINT fell 5.62% as two tracked medical-device peers (e.g., NXL, NVNO) also moved down around -2.8%, indicating pressure consistent with broader sector dynamics rather than company-specific news alone.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Mar 23 | Business update | Positive | +2.4% | Corporate update on first human implant, capital raise, and commercialization plans. |
| Mar 19 | Clinical milestone | Positive | -3.0% | First-in-human surgery using FDA-cleared SINAPTIC Foot & Ankle system. |
| Feb 18 | Leadership change | Positive | +0.3% | Appointment of Ryan Elmore as President to drive commercialization. |
| Jan 29 | Investor conference | Neutral | -2.4% | Participation in Noble Capital virtual equity conference with business updates. |
| Dec 08 | Investor conference | Neutral | +4.5% | Participation in Sidoti virtual investor conference with webcast and 1x1s. |
Reactions to news have been mixed, with both positive and negative moves following operational updates and conference appearances.
Over the last six months, SINTX has highlighted commercialization progress and leadership changes. A Mar 23, 2026 corporate update citing a capital raise and first human implant saw a modest gain, while the Mar 19, 2026 first-in-human surgery announcement coincided with a decline. Prior investor conference appearances in Jan 2026 and Dec 2025 produced small moves in both directions. Today’s LD Micro conference update continues this pattern of visibility-focused news amid ongoing strategic execution.
Regulatory & Risk Context
An effective S-3 resale registration dated Oct 23, 2025 covers up to 1,741,539 shares of common stock for selling stockholders. The company would only receive up to $8.3 million if related warrants are exercised for cash, earmarked for working capital and general corporate purposes.
Market Pulse Summary
This announcement focuses on SINTX’s participation in the LD Micro Invitational XVI, where management plans to discuss commercialization and product development across its silicon nitride biomaterials platform. Recent SEC filings show Q1 2026 revenue of $380,000, a net loss of $2.8 million, cash of $1.9 million, and an accumulated deficit of $295 million. Investors may watch future updates on revenue traction, cash management, and usage of existing ATM and S-3 capacities.
Key Terms
silicon nitride medical
biomaterials medical
AI-generated analysis. Not financial advice.
Salt Lake City, Utah--(Newsfile Corp. - May 17, 2026) - SINTX Technologies, Inc. (NASDAQ: SINT) ("SINTX" or the "Company"), a medical technology company focused on advanced ceramics and silicon nitride biomaterials, today announced that management will present at the LD Micro Invitational XVI Conference in Los Angeles, California, at the Luxe Sunset Blvd Hotel.
During the presentation, management expects to discuss recent progress in commercialization, product development, and manufacturing initiatives supporting the Company's silicon nitride biomaterials platform, including applications in orthopedics, spine, foot and ankle, and patient-specific implant markets.
"We are pleased to participate in the LD Micro Invitational and look forward to sharing recent developments across our business," said Ryan Elmore, President of SINTX Technologies. "Our focus remains on advancing our biomaterials platform and executing on opportunities that support long-term value creation."
Management will also be available for one-on-one meetings with investors, subject to scheduling availability.
Management will also be available for one-on-one meetings with institutional investors, family offices, and strategic partners throughout the conference.
Investors and interested parties may access the live webcast using the information below:
LD MICRO Invitational XVI Investor Conference
Presentation Date and Time: Tuesday, May 19, 2026 at 9:30 A.M. P.T.
Webcast: https://ldmicroevents.com
To schedule a one-on-one meeting with SINTX Technologies' management team, please email SINTX Technologies at ir@sintx.com
To be added to the Sintx Technologies email distribution list, please email ir@sintx.com with SINT in the subject line.
About SINTX Technologies, Inc.
Headquartered in Salt Lake City, Utah, SINTX Technologies, Inc. (NASDAQ: SINT) is an advanced ceramics company that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications.
SINTX Contacts:
SINTX Technologies, Inc.
801.839.3502
IR@sintx.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/297763